Bellerophon Therapeutics, Inc.

( )
BLPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 1.11%446.361.0%$797.93m
ABTAbbott Laboratories 1.08%117.260.8%$638.70m
MDTMedtronic Plc 2.53%118.190.6%$595.06m
DHRDanaher Corp. 1.91%218.500.7%$548.97m
BSXBoston Scientific Corp. 4.22%39.531.0%$462.99m
ISRGIntuitive Surgical, Inc. 0.59%713.372.3%$387.99m
BDXBecton, Dickinson & Co. 2.36%246.561.0%$363.36m
ALGNAlign Technology, Inc. 3.08%536.466.3%$347.14m
SYKStryker Corp. 1.90%240.271.3%$342.08m
DXCMDexCom, Inc. 2.20%364.097.8%$297.09m
IDXXIDEXX Laboratories, Inc. 2.85%499.703.8%$267.86m
BAXBaxter International, Inc. 2.21%78.111.8%$248.62m
ZBHZimmer Biomet Holdings, Inc. 1.37%158.391.7%$223.93m
EWEdwards Lifesciences Corp. -0.07%81.820.4%$220.70m
INOInovio Pharmaceuticals, Inc. 0.44%9.194.8%$204.46m

Company Profile

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD, and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.